NO20052177D0 - Anvendelse av galantamin og dets derivater for fremstilling av legemidler - Google Patents
Anvendelse av galantamin og dets derivater for fremstilling av legemidlerInfo
- Publication number
- NO20052177D0 NO20052177D0 NO20052177A NO20052177A NO20052177D0 NO 20052177 D0 NO20052177 D0 NO 20052177D0 NO 20052177 A NO20052177 A NO 20052177A NO 20052177 A NO20052177 A NO 20052177A NO 20052177 D0 NO20052177 D0 NO 20052177D0
- Authority
- NO
- Norway
- Prior art keywords
- galantamine
- drugs
- derivatives
- manufacture
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960003980 galantamine Drugs 0.000 title 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT15382003 | 2003-09-29 | ||
| PCT/AT2004/000251 WO2005030332A2 (de) | 2003-09-29 | 2004-07-12 | Verwendung von galanthamin und seinen derivaten zum herstellen von arzneimitteln |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052177D0 true NO20052177D0 (no) | 2005-05-03 |
| NO20052177L NO20052177L (no) | 2005-06-24 |
Family
ID=34382391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052177A NO20052177L (no) | 2003-09-29 | 2005-05-03 | Anvendelse av galantamin og dets derivater for fremstilling av legemidler |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060111341A1 (no) |
| EP (1) | EP1667769A2 (no) |
| CN (1) | CN1859949A (no) |
| CA (1) | CA2506282A1 (no) |
| MX (1) | MXPA05005570A (no) |
| NO (1) | NO20052177L (no) |
| WO (1) | WO2005030332A2 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| WO2008022365A2 (de) * | 2006-08-24 | 2008-02-28 | Sanochemia Ltd. | Mittel zum beeinflussen der wirkungen von organophosphorverbindungen und verwendung von galanthamin, dessen derivaten und analoga zum herstellen solcher mittel |
| WO2013160728A1 (en) | 2012-04-26 | 2013-10-31 | Alma Mater Studiorum - Universita' Di Bologna | Dual targeting compounds for the treatment of alzheimer's disease |
| CN104860955B (zh) * | 2015-04-22 | 2017-07-14 | 华东理工大学 | 加兰他敏类似物及其用途 |
| WO2017189834A1 (en) * | 2016-04-29 | 2017-11-02 | New Mexico Tech Research Foundation | Methods for treatment of resistant cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
| RO118419B1 (ro) * | 1994-10-21 | 2003-05-30 | Waldheim Pharmazeutika Gmbh | Procedeu de obtinere a derivatilor de 4a, 5, 9, 10, 11, 12-hexahidro-6h-benzofuro 3a, 3, 2- ef 2 benzazepina si intermediari care intervin in procedeu |
| US6407229B1 (en) * | 1994-10-21 | 2002-06-18 | Sanochemia Pharmazeutika Ag | Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine |
| GB9514821D0 (en) * | 1995-07-19 | 1995-09-20 | Sod Conseils Rech Applic | Galanthamine derivatives |
| NZ512546A (en) * | 1998-11-27 | 2002-11-26 | Sanochemia Pharmazeutika Ag | Use of actylcholine esterase inhibitors to treat delirium |
-
2004
- 2004-07-12 WO PCT/AT2004/000251 patent/WO2005030332A2/de not_active Ceased
- 2004-07-12 EP EP04737381A patent/EP1667769A2/de not_active Withdrawn
- 2004-07-12 MX MXPA05005570A patent/MXPA05005570A/es not_active Application Discontinuation
- 2004-07-12 CA CA002506282A patent/CA2506282A1/en not_active Abandoned
- 2004-07-12 US US10/537,568 patent/US20060111341A1/en not_active Abandoned
- 2004-09-09 CN CNA2004800283471A patent/CN1859949A/zh active Pending
-
2005
- 2005-05-03 NO NO20052177A patent/NO20052177L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005030332A3 (de) | 2005-06-02 |
| US20060111341A1 (en) | 2006-05-25 |
| CN1859949A (zh) | 2006-11-08 |
| NO20052177L (no) | 2005-06-24 |
| WO2005030332A2 (de) | 2005-04-07 |
| CA2506282A1 (en) | 2005-04-07 |
| EP1667769A2 (de) | 2006-06-14 |
| MXPA05005570A (es) | 2005-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
| NO20055246D0 (no) | Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav | |
| NO20055832D0 (no) | Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme | |
| NO20031448L (no) | Fremgangsmåte for fremstilling av nanopartikler av paclitaxel og albumin | |
| DK1620118T3 (da) | Reversible pegylerede lægemidler | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| IS7948A (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
| AU2003223207A8 (en) | Scds as modifiers of the p53 pathway and methods of use | |
| IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| DK1673349T3 (da) | Benzimidazolderivater: fremstilling og farmaceutiske anvendelser | |
| DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
| IL179757A0 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
| IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| PL377854A1 (pl) | Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania | |
| DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| IS6918A (is) | Meðferð erfiðra æxla með notkun epóþílon afleiða | |
| DK1590321T3 (da) | Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf | |
| PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna | |
| DK1682144T3 (da) | Smagsstofholdige lægemiddelformuleringer med forbedrede farmaceutiske egenskaber | |
| NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
| NO20054535D0 (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
| DK1475379T3 (da) | Anvendelse af scopinesterderivater til fremstilling af lægemidler | |
| NO20052859D0 (no) | Fremgangsmate for fremstilling av resperidon og intermediater derav | |
| NO20052177D0 (no) | Anvendelse av galantamin og dets derivater for fremstilling av legemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |